Abstract
Liver transplantation is now very successful with >85 % long term survival into adult life. When considering the impact of liver transplantation for metabolic disease two independent factors need to be considered; whether or not the defect causes liver disease and whether or not it is confined to the liver. When considering transplantation many factors need to be considered including the local success of transplantation, the impact of the metabolic disease on the patient and family and the potential for future therapeutic developments. Where transplantation is undertaken for a liver based defect there is a lifelong complete correction of the defect. Where there is a residual extrahepatic defect this will have an impact on the outcome of liver transplantation and the severity of this defect must be considered as part of the transplant assessment process. Access to a multi-disciplinary team with expertise in metabolic disease, liver disease and other relevant organ based specialists is crucial. Most children will receive transplantation from cadaveric donor but living related transplantation from a heterozygote parent is usually safe and effective. Auxiliary liver transplantation has a small but useful role where partial correction of the defect is helpful and there is a future prospect of gene therapy. The first-generation of hepatocyte transplants have shown proof of principle but to date have had a rather modest and temporary metabolic effect. Stem cells may have the potential to produce a more sustained and significant metabolic correction, but must be shown to be effective in controlled trials.
Similar content being viewed by others
References
Arnon R, Kerkar N, Davis MK, Anand R, Yin W, Gonzalez-Peralta RP (2010) Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience. Pediatr Transplant 14:796–805
Dowman JK, Watson D, Loganathan S, Gunson BK, Hodson J, Mirza DF, Clarke J, Lloyd C, Honeybourne D, Whitehouse JL, Nash EF, Kelly D, van Mourik I, Newsome PN (2012) Long-term impact of liver transplantation on respiratory function and nutritional status in children and adults with cystic fibrosis. Am J Transplant 12:954–964
Hughes RD, Mitry RR, Dhawan A (2012) Current status of hepatocyte transplantation. Transplantation 93:342–347
Leonard JV, McKiernan PJ (2004) The role of liver transplantation in urea cycle disorders. Mol Genet Metab 81(Suppl 1):S74–S78
Leonard JV, Walter JH, McKiernan PJ (2001) The management of organic acidaemias: the role of transplantation. J Inherit Metab Dis 24:309–311
McKiernan PJ (2011) Long-term care following paediatric liver transplantation. Arch Dis Child Educ Pract Ed 96:82–86
Mindikoglu AL, King D, Magder LS, Ozolek JA, Mazariegos GV, Shneider BL (2011) Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States. J Pediatr 158:802–807
Morioka D, Takada Y, Kasahara M, Ito T, Uryuhara K, Ogawa K, Egawa H, Tanaka K (2005) Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors. Transplantation 80:623–628
Nagasaka H, Yorifuji T, Egawa H, Kikuta H, Tanaka K, Kobayashi K (2001) Successful living-donor liver transplantation from an asymptomatic carrier mother in ornithine transcarbamylase deficiency. J Pediatr 138:432–434
Perera MT, Sharif K, Lloyd C, Foster K, Hulton SA, Mirza DF, McKiernan PJ (2011) Pre-emptive liver transplantation for primary hyperoxaluria (PH-I) arrests long-term renal function deterioration. Nephrol Dial Transplant 26:354–359
Popescu I, Dima SO (2012) Domino liver transplantation: how far can we push the paradigm? Liver Transpl 18:22–28
Puppi J, Strom SC, Hughes RD, Bansal S, Castell JV, Dagher I, Ellis EC, Nowak G, Ericzon BG, Fox IJ, Gomez-Lechon MJ, Guha C, Gupta S, Mitry RR, Ohashi K, Ott M, Reid LM, Roy-Chowdhury J, Sokal E, Weber A, Dhawan A (2012) Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 21:1–10
Rela M, Muiesan P, Vilca-Melendez H, Dhawan A, Baker A, Mieli-Vergani G, Heaton ND (1999) Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I. Ann Surg 229:565–569
Saland JM, Ruggenenti P, Remuzzi G (2009) Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol 20:940–949
Sokal EM, Sokol R, Cormier V, Lacaille F, McKiernan P, Van Spronsen FJ, Bernard O, Saudubray JM (1999) Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 158(Suppl 2):S81–S84
Strauss KA, Mazariegos GV, Sindhi R, Squires R, Finegold DN, Vockley G, Robinson DL, Hendrickson C, Virji M, Cropcho L, Puffenberger EG, McGhee W, Seward LM, Morton DH (2006) Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transplant 6:557–564
Sze YK, Dhawan A, Taylor RM, Bansal S, Mieli-Vergani G, Rela M, Heaton N (2009) Pediatric liver transplantation for metabolic liver disease: experience at King’s College Hospital. Transplantation 87:87–93
Yusa K, Rashid ST, Strick-Marchand H, Varela I, Liu PQ, Paschon DE, Miranda E, Ordonez A, Hannan NR, Rouhani FJ, Darche S, Alexander G, Marciniak SJ, Fusaki N, Hasegawa M, Holmes MC, Di Santo JP, Lomas DA, Bradley A, Vallier L (2011) Targeted gene correction of alpha(1)-antitrypsin deficiency in induced pluripotent stem cells. Nature 478:391–394
Zuber J, Quintrec ML, Krid S, Bertoye C, Gueutin V, Lahoche A, Heyne N, Ardissino G, Chatelet V, Noel LH, Hourmant M, Niaudet P, Bacchi V, Rondeau E, Legendre C, Loirat C (2012) Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant 12:3337–3354
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: K. Michael Gibson
Rights and permissions
About this article
Cite this article
McKiernan, P. Liver transplantation and cell therapies for inborn errors of metabolism. J Inherit Metab Dis 36, 675–680 (2013). https://doi.org/10.1007/s10545-012-9581-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-012-9581-z